Zylox-Tonbridge Medical Technology Co. Ltd (2190.HK) released a profit for its full year that Increased, from last year
The company's bottom line came in at RMB244.37 million, or RMB0.7552 per share. This compares with RMB100.25 million, or RMB0.3057 per share, last year.
The company's revenue for the period rose 35.1% to RMB1.057 billion from RMB782.48 million last year.
Zylox-Tonbridge Medical Technology Co. Ltd earnings at a glance (GAAP) :
-Earnings: RMB244.37 Mln. vs. RMB100.25 Mln. last year.-EPS: RMB0.7552 vs. RMB0.3057 last year.-Revenue: RMB1.057 Bln vs. RMB782.48 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.